Skp2 Inhibits FOXO1 in Tumor Suppression Through Ubiquitin-mediated Degradation

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2005 Jan 26

PMID 15668399

Citations 249

Authors

Haojie Huang

Kevin M Regan

Fang Wang

Diping Wang

David I Smith

Jan M A van Deursen

Donald J Tindall

Affiliations

Soon will be listed here.

Abstract

Forkhead transcription factors FOXO1 (FKHR), FOXO3a (FKHRL1), and FOXO4 (AFX) play a pivotal role in tumor suppression by inducing growth arrest and apoptosis. Loss of function of these factors due to phosphorylation and proteasomal degradation has been implicated in cell transformation and malignancy. However, the ubiquitin ligase necessary for the ubiquitination of the FOXO factors and the relevance of this regulation to tumorigenesis have not been characterized. Here we demonstrate that Skp2, an oncogenic subunit of the Skp1/Cul1/F-box protein ubiquitin complex, interacts with, ubiquitinates, and promotes the degradation of FOXO1. This effect of Skp2 requires Akt-specific phosphorylation of FOXO1 at Ser-256. Moreover, expression of Skp2 inhibits transactivation of FOXO1 and abolishes the inhibitory effect of FOXO1 on cell proliferation and survival. Furthermore, expression of the FOXO1 protein is lost in a mouse lymphoma model, where Skp2 is overexpressed. These data suggest that the Skp2-promoted proteolysis of FOXO1 plays a key role in tumorigenesis.

Citing Articles

Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies.

Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A Mol Cancer. 2025; 24(1):58.

PMID: 40011944 PMC: 11863469. DOI: 10.1186/s12943-025-02267-0.

Rebastinib inhibits FoxO1 activity and reduces dexamethasone-induced atrophy and its-related gene expression in cultured myotubes.

Sato T, Morita A, Watanabe Y, Naito Y, Kawaji H, Nakagawa T J Physiol Sci. 2025; 75(1):100012.

PMID: 39985917 PMC: 11905838. DOI: 10.1016/j.jphyss.2025.100012.

LKB1 dictates sensitivity to immunotherapy through Skp2-mediated ubiquitination of PD-L1 protein in non-small cell lung cancer.

Lv L, Miao Q, Zhan S, Chen P, Liu W, Lv J J Immunother Cancer. 2024; 12(12).

PMID: 39694700 PMC: 11660338. DOI: 10.1136/jitc-2024-009444.

CARD16 restores tumorigenesis and restraints apoptosis in glioma cells Via FOXO1/TRAIL axis.

Xuan R, Hu T, Cai L, Zhao B, Han E, Xia Z Cell Death Dis. 2024; 15(11):804.

PMID: 39516471 PMC: 11549220. DOI: 10.1038/s41419-024-07196-2.

Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer.

Xu P, Yang J, Chen B, Ning S, Zhang X, Wang L Nat Commun. 2024; 15(1):6626.

PMID: 39103353 PMC: 11300456. DOI: 10.1038/s41467-024-50459-x.

References

Siegel D, Anwar A, Winski S, Kepa J, Zolman K, Ross D . Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol Pharmacol. 2001; 59(2):263-8. DOI: 10.1124/mol.59.2.263. View

Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers W . Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol. 2000; 20(23):8969-82. PMC: 86551. DOI: 10.1128/MCB.20.23.8969-8982.2000. View

Mamillapalli R, Gavrilova N, Mihaylova V, Tsvetkov L, Wu H, Zhang H . PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr Biol. 2001; 11(4):263-7. DOI: 10.1016/s0960-9822(01)00065-3. View

Carrano A, Pagano M . Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression. J Cell Biol. 2001; 153(7):1381-90. PMC: 2150734. DOI: 10.1083/jcb.153.7.1381. View

Huang H, Cheville J, Pan Y, Roche P, Schmidt L, Tindall D . PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. J Biol Chem. 2001; 276(42):38830-6. DOI: 10.1074/jbc.M103632200. View

Lee S, Ramos S, Ko A, Masiello D, Swanson K, Lu M . AR and ER interaction with a p21-activated kinase (PAK6). Mol Endocrinol. 2002; 16(1):85-99. DOI: 10.1210/mend.16.1.0753. View

Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers W . A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell. 2002; 2(1):81-91. DOI: 10.1016/s1535-6108(02)00086-7. View

Yang G, Ayala G, De Marzo A, Tian W, Frolov A, Wheeler T . Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res. 2002; 8(11):3419-26. View

Tedesco D, Lukas J, Reed S . The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev. 2002; 16(22):2946-57. PMC: 187481. DOI: 10.1101/gad.1011202. View

10.

Modur V, Nagarajan R, Evers B, Milbrandt J . FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem. 2002; 277(49):47928-37. DOI: 10.1074/jbc.M207509200. View

11.

Zhang L, Wang C . PAX3-FKHR transformation increases 26 S proteasome-dependent degradation of p27Kip1, a potential role for elevated Skp2 expression. J Biol Chem. 2002; 278(1):27-36. DOI: 10.1074/jbc.M205424200. View

12.

Plas D, Thompson C . Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J Biol Chem. 2003; 278(14):12361-6. DOI: 10.1074/jbc.M213069200. View

13.

Shim E, Johnson L, Noh H, Kim Y, Sun H, Zeiss C . Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate. Cancer Res. 2003; 63(7):1583-8. View

14.

Gilley J, Coffer P, Ham J . FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol. 2003; 162(4):613-22. PMC: 2173804. DOI: 10.1083/jcb.200303026. View

15.

Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H . Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci U S A. 2003; 100(18):10231-6. PMC: 193544. DOI: 10.1073/pnas.1831009100. View

16.

Matsuzaki H, Daitoku H, Hatta M, Tanaka K, Fukamizu A . Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc Natl Acad Sci U S A. 2003; 100(20):11285-90. PMC: 208749. DOI: 10.1073/pnas.1934283100. View

17.

Kang-Decker N, Tong C, Boussouar F, Baker D, Xu W, Leontovich A . Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency. Cancer Cell. 2004; 5(2):177-89. DOI: 10.1016/s1535-6108(04)00022-4. View

18.

Huang H, Muddiman D, Tindall D . Androgens negatively regulate forkhead transcription factor FKHR (FOXO1) through a proteolytic mechanism in prostate cancer cells. J Biol Chem. 2004; 279(14):13866-77. DOI: 10.1074/jbc.M314143200. View

19.

Hu M, Lee D, Xia W, Golfman L, Ou-Yang F, Yang J . IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell. 2004; 117(2):225-37. DOI: 10.1016/s0092-8674(04)00302-2. View

20.

Accili D, Arden K . FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004; 117(4):421-6. DOI: 10.1016/s0092-8674(04)00452-0. View